82. Ferris, R.L., et al., Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N Engl J Med, 2016. 375(19): p. 1856-1867. 83. El-Naggar, A.K. and W.H. Westra, p16 expression as a surrogate marker for HPV - related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck, 2012. 34(4): p. 459-61. Abbreviated T itle: STAT Trial Version Date : 08/17/2022 123 84. Marur, S., et al., HPV -associated head and neck cancer: a virus -related cancer epidemic. Lancet Oncol, 2010. 11(8): p. 781-9. 85. Lydiatt, W.M., et al., Head and Neck cancers -major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin, 2017. 67(2): p. 122-137. 86. Chaturvedi, A.K., et al., Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol, 2011. 29(32): p. 4294-301.